41078 Federal Register / Vol. 65, No. 128 / Monday, July 3, 2000 / Notices

F. Submission and Deadline

Submit the original and two copies of

the application including the PHS Form

5161–1 (OMB Number 0937–0189) on or

before July 28, 2000 to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

Deadline: Applications shall be

considered as meeting the deadline if

they are either:

(a) Received on or before the deadline

date; or

(b) Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.)

Late Applications: Applications

which do not meet the criteria in (a) or

(b) above are considered late

applications, will not be considered,

and will be returned to the applicant.

G. Evaluation Criteria

Each application will be evaluated

individually against the stated criteria

by an independent review group

appointed by CDC. Evaluation Criteria

instructions specific to each focus area

may be found in Attachments 1–3.

H. Other Requirements

Technical Reporting Requirements:

Provide CDC with an original plus two

copies of:

1. Annual progress report, no more

than 90 days after the end of the budget

period;

2. Financial status report, no more

than 90 days after the end of the budget

period; and

3. Final financial and performance

report, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

announcement. For a complete

description of each, See Attachment IV

in the application kit.

AR–1 Human Subjects Requirements

AR–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–4 HIV/AIDS Confidentiality

Provisions

AR–5 HIV Program Review Panel

Requirements

AR–7 Executive Order 12372 Review

AR–9 Paperwork Reduction

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

section 317E of the Public Health

Service Act, 42 U.S.C. section 42 U.S.C.

247b–6, as amended. The Catalog of

Federal Domestic Assistance number is

93.947.

J. Where To Obtain Additional

Information

This and other CDC Announcements

can be found on the CDC homepage on

the Internet address http://www.cdc.gov

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements’’.

To obtain additional information,

contact: Carrie Clark, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 2920

Brandywine Road, Room 3000, Atlanta,

GA 30341–2783, Telephone (770) 488–

2783, E-mail address: zri4@cdc.gov

Programmatic technical assistance

may be obtained from: Juanita Elder,

Division of Tuberculosis Elimination,

National Center for Prevention Services,

Centers for Disease Control and

Prevention (CDC), 1600 Clifton Road,

NE., Mailstop E–10, Atlanta, GA 30333,

Telephone (404) 639–8120, Email

Address: jlc7@cdc.gov.

Dated: June 27, 2000.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 00–16718 Filed 6–30–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability and Injury

Prevention and Control Special

Emphasis Panel: Fiscal Year 2000

Competitive Supplemental Funds for

Comprehensive STD Prevention

Systems: Monitoring Trends in STD

Prevalence, Tuberculosis, and HIV

Risk Behaviors Among Men Who Have

Sex With Men, PA# 99000–H

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Disease, Disability and Injury

Prevention and Control Special Emphasis

Panel: Fiscal Year 2000 Competitive

Supplemental Funds for Comprehensive STD

Prevention Systems: Monitoring Trends in

STD Prevalence, Tuberculosis, and HIV Risk

Behaviors among Men who have Sex with

Men, PA# 99000–H.

Times and Dates: 8:30 a.m.–9 a.m., August

4, 2000 (Open), 9 a.m.–4:30 p.m., August 4,

2000 (Closed).

Place: Centers for Disease Control and

Prevention, Corporate Square, Building 11,

Conference Room 2214, Atlanta, Georgia

30329.

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c)(4) and

(6), title 5 U.S.C., and the Determination of

the Associate Director for Management and

Operations, CDC, pursuant to Public Law 92–

463.

Matters to be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcement 99000–

H.

Contact Person for more Information: Beth

Wolfe, Prevention Support Office, National

Center for HIV, STD, and TB Prevention,

CDC, Corporate Square Office Park, 11

Corporate Square Boulevard, M/S E07,

Atlanta, Georgia 30329, telephone 404/639–

8025, e-mail eow1@cdc.gov.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 23, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–16720 Filed 6–30–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability and Injury

Prevention and Control Special

Emphasis Panel: Community-Based

Strategies To Increase HIV Testing of

Persons at High Risk in Communities

of Color, PA# 00100

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Disease, Disability and Injury

Prevention and Control Special Emphasis